Jean-Paul Behr

[1] Research director at the CNRS, he is known for his work in the field of nucleic acid vectorization.

After a doctorate in physical organic chemistry under the supervision of Jean-Marie Lehn (1973) followed by a postdoctoral internship in England, he founded the Genetic Chemistry Laboratory at the Faculty of Pharmacy in Strasbourg.

His research there focused mainly on the development of molecules capable of encapsulating DNA and transporting it inside living cells.

Jean-Paul Behr developed the first effective lipid vectors,[2][3] then polymeric,[4] which were marketed under the names TransfectamTM, LipofectamineTM and jetPEITM.

These vectors are widely used as transfection agents for animal cells in culture, but also as drug-gene carriers in clinical gene therapy trials.